| Abaxis is engaged in developing, manufacturing and marketing portable blood analysis systems for use in the human or veterinary patient-care to provide clinicians with blood constituent measurements. Co. has two business segments: medical market, with products manufactured and sold in this segment primarily consist of Piccolo chemistry analyzers and medical reagent discs; and veterinary market, with product offerings that include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests. We show 36 historical shares outstanding datapoints in our coverage of ABAX's shares outstanding history.|
Understanding the changing numbers of ABAX shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ABAX versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ABAX by allowing them to research ABAX shares outstanding history
as well as any other stock in our coverage universe.